球蛋白与维持性血液透析患者预后的相关性

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
汪宣贝
文章摘要
目的:分析球蛋白与维持性血液透析(MHD)患者预后的相关性。方法:本研究选取2015年1月-2022年12月简阳市人民医院收治的312例血液透析患者为研究对象,球蛋白水平波动于15.9-60.2之间,根据球蛋白中位数(25.9)将患者分为高球蛋白组(n=156)和低球蛋白组(n=156),分析患者的生存情况采用Kaplan-Meier法,分析球蛋白对血液透析患者全因死亡的影响采用COX比例风险模型。结果:(1)根据研究数据可知,高球蛋白组与低球蛋白组在性别、身高、体重、BMI、血红蛋白、尿素氮、肌酐、尿酸、血糖、血钙、血磷、甘油三脂、总胆固醇、IPTH、铁蛋白等方面无统计学差异(p>0.05),由统计分析可知高球蛋白组较于低球蛋白组血小板计数及平均年龄较于低球蛋白组存在显著性差异,且其收缩压舒张压较于对照组较低(p<0.05)。(2)患者中位随访时间42(28,57)个月,死亡75例(19.2%),死亡原因分别为:心血管疾病50例(80%)、感染13例(8.3%)、其它12例(11.6%)。与低球蛋白组患者相比,高球蛋白组患者死亡率均较高(P<0.05)。(3)Kaplan-Meier分析显示,低球蛋白组患者累积全因生存率(P<0.001)优于高球蛋白组患者。(4)基于COX比例风险回归模型分析的结果显示,未校正的初始模型中,高球蛋白水平组患者全因死亡风险相比于对照组显著升高(HR=2.039),经过多因素校正后,该组患者全因死亡风险虽有所降低,但仍然处于较高的水平(HR:1.977),统计学差异仍然显著,再进一步加入更多的控制变量进行修正后,高球蛋白仍然是增加全因死亡风险(HR:1.825)的独立风险因素。
文章关键词
血液透析;球蛋白;预后;相关性
参考文献
[1] Kovesdy CP.Clinicaltrial sinend—stagerenal disease—prioritiesand challenges[J].NephrolDialTransplant,2019,34(7):1084—1089. [2] Pifer TB,McCullough KP,Port FK et al.Mortality risk in hemodialysis patients and changes in nutritional indicators:DOPPS.Kidney Int 2002;62:2238–2245. [3] Herselman M,Esau N,Kruger JM et al.Relationship between serumprotein and mortality in adults on long-term hemodialysis:exhaustive review and meta-analysis.Nutrition 2010;26:10–32. [4] Bergstrom J,Lindholm B,Lacson E Jr et al.What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?SeminDial2000;13:163–164. [5] Busher JT.Serum albumin and globulin.In:Walker,HK,Hall WD Hurst JW(eds).Clinical Methods:The History,Physical,and Laboratory Examinations.Boston:Butterworths,1990. [6] Peng F,Sun L,Chen T et al.Albumin–globulin ratio and mortality in of 148 patients with polyclonal gammopathy.Mayo Clin Proc 2001;76:476–48 patientson peritoneal dialysis:a retrospective study.BMC Nephrol 2020;21:51. [7] Dispenzieri A,Gertz MA,Therneau TM et al.Retrospective cohort study of 148 patients with polyclonal gammopathy.Mayo Clin Proc 2001;76:476–487. [8] Kalantar-Zadeh K,Ikizler TA,Block G et al.Malnutrition–inflammation complex syndrome in dialysis patients:causes and consequences. Am J Kidney Dis2003;42:864–881. [9] Locatelli F,Canaud B,Eckardt KU et al.Oxidative stress in end-stage renal disease:an emerging threat to patient outcome.Nephrol Dial Transplant 2003;18:1272–1280. [10] Noh H,Lee SW,Kang SW et al.Serum C-reactive protein:a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit DialInt 1998;18:387–394. [11] Selim G,Stojceva-Taneva O,Zafirovska K et al.Inflammation predictsall-cause and cardiovascular mortality in haemodialysis patients. Prilozi 2006;27:133–144. [12] 胡大一,周玉杰.Topol心血管病学[M].北京:人民卫生出版社,2009. [13] 徐冷楠,陈献广,李天慧等.单中心20年间维持性血液透析患者亡原因分析[J].中华老年医学杂志,2018,37(10):1111-1114. [14] Bramania PK,Ruggajo P,Bramania R,et al.Prevalence of malnutritioninflammation complex syndrome among patients on maintenance haemodialysis at Muhimbili National Hospital in Tanzania:a cross-sectional study[J].BMC Nephrol,2020,21(1):521. [15] O’Connell TX,Horita TJ,Kasravi B.Understanding and interpreting serum protein electrophoresis.Am Fam Physician 2005;71:105–112. [16] Vavricka SR,Burri E,Beglinger C et al.Serum protein electrophoresis:an underused but very useful test.Digestion 2009;79:203–210 [17] Sims FH,Gavin JB,Edgar S et al.Diffusion of gamma globulin into the arterial wall identifies localized entry of lipid and cells in atherosclerosis.Coron Artery Dis 2001;12:21–30. [18] Tsiantoulas D,Diehl CJ,Witztum JL et al.B cells and humoral immunity in atherosclerosis.Circ Res 2014;114:1743–1756. [19] Boixeda R,Capdevila JA,Vicente V et al.Gamma globulin fraction ofthe proteinogram and chronic obstructive pulmonary disease exacerbations.Med Clin(Barc)2017;149:107–113.
Full Text:
DOI